This underscores the need for further research into the sequencing, structure, and functional role of SMN2 in SMA, to enable more precise use of costly and often lifelong therapies across all age groups, particularly considering the potential differences in adults with long-standing disease [40]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.